Meihua International Medical Technologies (NASDAQ:MHUA) Shares Down 55.4% – What’s Next?

Shares of Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUAGet Free Report) were down 55.4% on Friday . The company traded as low as $7.36 and last traded at $6.25. Approximately 153,423 shares traded hands during mid-day trading, an increase of 645% from the average daily volume of 20,602 shares. The stock had previously closed at $14.02.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Meihua International Medical Technologies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Meihua International Medical Technologies currently has an average rating of “Sell”.

Check Out Our Latest Analysis on Meihua International Medical Technologies

Meihua International Medical Technologies Stock Down 55.4%

The firm has a fifty day moving average of $13.99 and a 200 day moving average of $30.77.

Meihua International Medical Technologies Company Profile

(Get Free Report)

Meihua International Medical Technologies Inc is a Nasdaq‐listed company primarily engaged in the development, manufacturing and distribution of disposable medical gloves. Through its wholly owned operating subsidiaries in Wenzhou, Zhejiang Province, China, Meihua produces a range of nitrile and latex gloves designed for medical, industrial and consumer applications. The company’s operations include end‐to‐end glove production—from raw material processing to finished goods packaging—ensuring quality control across each stage of manufacture.

The company’s product offering comprises examination gloves, surgical gloves, industrial‐use gloves and household gloves.

See Also

Receive News & Ratings for Meihua International Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meihua International Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.